![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
5 min
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
Biosimilars Gastroenterology Roundup for May 2024—Podcast Edition Not So Different: A Podcast from The Center for Biosimilars
-
- Health & Fitness
On this episode of Not So Different, we review the biggest gastroenterology biosimilar stories from May 2024, covering new data from conferences and journals on infliximab and adalimumab products that demonstrate positive clinical results and confirm the safety of these biosimilars and the feasibility of switching to them.
On this episode of Not So Different, we review the biggest gastroenterology biosimilar stories from May 2024, covering new data from conferences and journals on infliximab and adalimumab products that demonstrate positive clinical results and confirm the safety of these biosimilars and the feasibility of switching to them.
5 min